Characterization of carbapenem nonsusceptible pseudomonas aeruginosa in Denmark: A nationwide, prospective study

Microbial Drug Resistance

Volumn 20, Issue 1, 2014, Pages 22-29

  Hansen, Frank ^a   Johansen, Helle Krogh ^b   Østergaard, Claus ^c   Arpi, Magnus ^d   Hansen, Dennis Schrøder ^e   Littauer, Pia ^f   Holm, Anette ^g   Heltberg, Ole ^h   Schumacher, Helga ⁱ   Fuursted, Kurt ^j   Lykke, Mari Ann Domar ^k   Tønning, Birgitte ^l   Hammerum, Anette M ^a   Justesen, Ulrik Stenz ^m  

^a STATENS SERUM INSTITUT   (Denmark)

^b Rigshospitalet   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e HILLERØD HOSPITAL   (Denmark)

^f HVIDOVRE HOSPITAL   (Denmark)

^g LILLEBAELT HOSPITAL   (Denmark)

^h SLAGELSE HOSPITAL   (Denmark)

ⁱ Regionshospitalet Herning ^*  (Denmark)

^j AARHUS UNIVERSITY HOSPITAL   (Denmark)

^k ESBJERG HOSPITAL   (Denmark)

^l VIBORG HOSPITAL   (Denmark)

^m ODENSE UNIVERSITY HOSPITAL   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINO PHENYLBORONIC ACID; AMINOGLYCOSIDE; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; CLOXACILLIN; DIPICOLINIC ACID; DORIPENEM; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM EXAMINATION; BACTERIUM ISOLATE; DENMARK; MOLECULAR TYPING; NONHUMAN; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CYSTIC FIBROSIS; DENMARK; ELECTROPHORESIS, GEL, PULSED-FIELD; GENE EXPRESSION; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEROTYPING;

EID: 84893773378     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2013.0085     Document Type: Article

References (42)

1. Bogaerts, P., C. Bauraing, A. Deplano, and Y. Glupczynski. 2007. Emergence and dissemination of BEL-1-producing Pseudomonas aeruginosa isolates in Belgium. Antimicrob. Agents. Chemother. 51:1584-1585.
2. Cabot, G., A.A. Ocampo-Sosa, F. Tubau, M.D. Macia, C. Rodríguez, B. Moya, et al. 2011. Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study. Antimicrob. Agents. Che-mother. 55:1906-1911.
3. Cholley, P., M. Thouverez, D. Hocquet, N. van der Mee-Marquet, D. Talon, and X. Bertrand. 2011. Most multidrug-resistant Pseudomonas aeruginosa isolates from hospitals in eastern France belong to a few clonal types. J. Clin. Micro-biol. 49:2578-2583.
4. CLSI. 2012. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Ninth Edition.
5. Cornaglia, G., H. Giamarellou, and G.M. Rossolini. 2011. Metallo-b-lactamases: a last frontier for b-lactams? Lancet Infect. Dis. 11:381-393.
6. Curran, B., D. Jonas, H. Grundmann, T. Pitt, and C.G. Dowson. 2004. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J. Clin. Microbiol. 42:5644-5649.
7. Dallenne, C., A. Da Costa, D. Decré, C. Favier, and G. Arlet. 2010. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J. Antimicrob. Chemother. 65:490-495.
8. DANMAP. 2007. September 2008 ISSN 1600-2032.
9. DANMAP. 2011. Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. ISSN. 1600-2032.
10. Delbrü ck, H., P. Bogaerts, M.B. Kupper, R. Rezende de Castro, S. Bennink, Y. Glupczynski, et al. 2012. Kinetic and crystallographic studies of extended-spectrum GES-11, GES-12, and GES-14 b-lactamases. Antimicrob. Agents. Che-mother. 56:5618-5625.
11. ECDC. 2012. Antimicrobial resistance surveillance in Europe 2011. Annual Report of the European Antimicrobial Resistance Network (EARS-Net). Stockholm: ECDC.
12. Ellington, M.J., J. Kistler, D.M. Livermore, and N. Woodford. 2007. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J. Antimicrob. Chemother. 59:321-322.
13. Empel, J., K. Filczak, A. Mrówka, W. Hryniewicz, D.M. Livermore, and M. Gniadkowski. 2007. Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum beta-lactamase in Warsaw, Poland: further evidence for an international clonal complex. J. Clin. Microbiol. 45:2829-2834.
14. Erratum DANMAP. 2011.
15. EUCAST. 2012. Antimicrobial susceptibility testing EU-CAST disk diffusion method.
16. Fera, M.T., and S. Zummo, A. DE Sarro. 2011. In vitro activity studies of doripenem and two other carbapenems tested against Pseudomonas aeruginosa and other non-fermentative bacilli. J. Chemother. 23:335-340.
17. Furtado, G.H.C., M.D. Bergamasco, F.G. Menezes, D. Marques, A. Silva, L.B. Perdiz, et al. 2009. Imipenem-resistant Pseudomonas aeruginosa infection at a medical-surgical intensive care unit: risk factors and mortality. J. Crit. Care 24:625.e9-e14.
18. Giske, C.G., L. Buarø, A. Sundsfjord, and B. Wretlind. 2008. Alterations of porin, pumps, and penicillin-binding proteins in carbapenem resistant clinical isolates of Pseudomonas aeruginosa. Microb. Drug Resist. 14:23-30.
19. Hansen, D.S., H. Schumacher, F. Hansen, M. Stegger, F.B. Hertz, K. Schønning, et al. 2012. Extended-spectrum b-lac-tamase (ESBL) in Danish clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence, b-lactamase distribution, phylogroups, and co-resistance. Scand. J. Infect. Dis. 44:174-181.
20. Jeong, J.H., K.S. Shin, J.W. Lee, E.J. Park, and S.-Y. Son. 2009. Analysis of a novel class 1 integron containing metallo-beta-lactamase gene VIM-2 in Pseudomonas aeruginosa. J. Microbiol. 47:753-759.
21. Johansen, H.K., S.M. Moskowitz, O. Ciofu, T. Pressler, and N. Høiby. 2008. Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients. J. Cyst. Fibros. 7:391-397.
22. Juan, C., O. Gutie, C. Vidal, L. Pe, A. Oliver, J.E.T. Al, et al. 2005. Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains. Antimicrob. Agents Chemother. 49:4733-4738.
23. Kiratisin, P., R.A. Keel, and D.P. Nicolau. 2013. Pharma-codynamic profiling of doripenem, imipenem and mer-openem against prevalent Gram-negative organisms in the Asia-Pacific region. Int. J. Antimicrob. Agents. 41:47-51.
24. Koh, T.H., C.T. Khoo, T.T. Tan, M.A.B.M. Arshad, L.P. Ang, L.J. Lau, et al. 2010. Multilocus sequence types of carbapenem-resistant Pseudomonas aeruginosa in Singapore carrying metallo-beta-lactamase genes, including the novel bla(IMP-26) gene. J. Clin. Microbiol. 48:2563-2564.
25. Lagatolla, C., E.A. Tonin, C. Monti-bragadin, L. Dolzani, F. Gombac, C. Bearzi, et al. 2004. Endemic Carbapenem-re-sistant Pseudomonas aeruginosa with acquired metallo-b-lac-tamase determinants in a European hospital. Emerg. Infect. Dis. 10:3-6.
26. Leblebicioglu, H., N. Cakir, M. Celen, H. Kurt, H. Baris, and J. Laeuffer. 2012. Comparative activity of carbapenem testing (the COMPACT study) in Turkey. BMC Infect. Dis. 12:42.
27. Lister, P.D., D.J. Wolter, and N.D. Hanson. 2009. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol. Rev. 22:582-610.
28. Maatallah, M., J. Cheriaa, A. Backhrouf, A. Iversen, H. Grundmann, T. Do, et al. 2011. Population structure of Pseudomonas aeruginosa from five Mediterranean countries: evidence for frequent recombination and epidemic occurrence of CC235. PLoS One 6:e25617.
29. Magiorakos, A., A. Srinivasan, R.B. Carey, Y. Carmeli, M.E. Falagas, C.G. Giske, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18: 268-281.
30. Michalopoulos, A.S., and M.E. Falagas. 2011. Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients. Ann. Intensive Care 1:30.
31. Miriagou, V., G. Cornaglia, M. Edelstein, I. Galani, C.G. Giske, M. Gniadkowski, et al. 2010. Acquired carbapene-mases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin. Microbiol. Infect. 16:112-122.
32. Paramythiotou, E., J.-C. Lucet, J.-F. Timsit, D. Vanjak, C. Paugam-Burtz, J.-L. Trouillet, et al. 2004. Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with anti-pseudomonal activity. Clin. Infect. Dis. 38:670-677.
33. Pasteran, F., D. Faccone, S. Gomez, S. De Bunder, F. Spinelli, M. Rapoport, et al. 2012. Detection of an international multi-resistant clone belonging to sequence type 654 involved in the dissemination of KPC-producing Pseudomonas aeruginosa in Argentina. J. Antimicrob. Chemother. 67:1291-1293.
34. Pasteran, F., O. Veliz, M. Rapoport, L. Guerriero, and A. Corso. 2011. Sensitive and specific modified Hodge test for KPC and metallo-beta-lactamase detection in Pseudomonas aeruginosa by use of a novel indicator strain, Klebsiella pneumoniae ATCC 700603. J. Clin. Microbiol. 49: 4301-4303.
35. Peña, C., C. Suarez, M. Gozalo, J. Murillas, B. Almirante, V. Pomar, et al. 2012. Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections. Antimicrob. Agents. Chemother. 56:1265-1272.
36. Riera, E., G. Cabot, X. Mulet, M. García-Castillo, R. del Campo, C. Juan, et al. 2011. Pseudomonas aeruginosa carba-penem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. J. Antimicrob. Chemother. 66:2022-2027.
37. Rodríguez-Martínez, J.-M., L. Poirel, and P. Nordmann. 2009. Molecular epidemiology and mechanisms of carbape-nem resistance in Pseudomonas aeruginosa. Antimicrob. Agents. Chemother. 53:4783-4788.
38. Samuelsen, O., M. a Toleman, A. Sundsfjord, J. Rydberg, T.M. Leegaard, M. Walder, et al. 2010. Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion. Anti-microb. Agents. Chemother. 54:346-352.
39. Strateva, T., and D. Yordanov. 2009. Pseudomonas aeruginosa- a phenomenon of bacterial resistance. J. Med. Microbiol. 58:1133-1148.
40. Tsakris, A., A. Poulou, I. Kristo, T. Pittaras, N. Spanakis, S. Pournaras, et al. 2009. Large dissemination of VIM-2-me-tallo-{beta}-lactamase- producing Pseudomonas aeruginosa strains causing health care-associated community-onset infections. J. Clin. Microbiol. 47:3524-3529.
41. Van der Bij, A.K., D. Van der Zwan, G. Peirano, J.A. Se-verin, J.D. Pitout, M. Van Westreenen, W.H. Goessens, MBL-PA Surveillance Study Group. 2012. Metallo-b-lacta-mase-producing Pseudomonas aeruginosa in the Netherlands: the nationwide emergence of a single sequence type. Clin. Microbiol. Infect. 18: E369-E372.
42. Vatcheva-Dobrevska, R., X. Mulet, I. Ivanov, L. Zamorano, E. Dobreva, T. Velinov, et al. 2013. Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeru-ginosa isolates from Bulgarian hospitals. [Epub ahead of print]; DOI: 10.1089/mdr.2013-0004.